pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many companies have several projects ongoing simultaneously, which can limit internal resources (space, lab equipment, personnel) and delay progress.

Reagent 52

Reagent DNA Scientist Drugs 52

XTalks

AUGUST 18, 2020

SalivaDirect, a saliva-based COVID-19 test that was tested among players of the National Basketball Association (NBA), has been given emergency use authorization (EUA) by the US Food and Drug Administration (FDA). The EUA comes after Yale partnered with the NBA to study the efficacy of the saliva-based test.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Drug Discovery World

APRIL 3, 2023

Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. Equally, the controlled chemistry of Optimer offers the ability for precise aptamer-drug ratios, with conjugation at specific sites on the molecule to simplify therapeutic manufacture.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry. Key Moments.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

OCTOBER 14, 2020

The AOP Orphan Group manufactures 80% of its drugs in Europe and has more than 20 subsidiaries and representative offices across the whole of Europe as well as in the United Arab Emirates and Israel. Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52

Drug Discovery World

AUGUST 23, 2023

There’s even a name for the downsides of such under-supported products, poor integrations, and bad user experience: frustrated ELN users call this the “tax on science” That tax has a real cost in terms of drug discovery. This transition improved intellectual property management for early drug discovery.

Laboratory Information Management System 52

Laboratory Information Management System Scientist Compliance Development 52